NCT05174832 2023-09-28
Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients
Fudan University
Phase 2 Unknown
Clinical Trials
6 trialsNCT04297267 2022-07-22
nonpCR GP
Fudan University
Phase 2 Unknown
NCT02341911 2022-04-20
TNBC
Fudan University
Phase 2 Unknown
NCT04192903 2022-04-20
Chidamide Combined With Cisplatin for Relapsed or Metastatic Triple-negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT04517292 2020-08-18
GEP
Fudan University
Phase 2 Unknown
NCT01928680 2015-02-23
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
ChineseAMS
Phase 2 Unknown